Ryman rights trading ends on a sour note

Ryman rights trading ends on a sour note
Salt Funds' Matt Goodson said time will tell whether Ryman shares are cheap. (Image: Salt Funds)
Jenny Ruth
Ryman Healthcare’s $902 million rights issue is drawing to a dismal close, with the price of the rights falling as low as 7.5 cents on Tuesday, the last day of trading.Two weeks ago, in the institutional book-build auction process, institutional investors were prepared to pay an effective $1 for the rights.You could say that was a little disappointing because the theoretical value of the rights price was $1.03 – institutions paid $6 for the shares issued at $5, so the additional price paid reflected the value they put on the rights....

More Finance

Todd Corporation: the reset
Finance

Todd Corporation: the reset

Legacy gas assets will give way to a focus on solar electricity generation.

Pattrick Smellie 13 Dec 2024
Kiwibank won't bring banking Revolut-ion
Finance

Kiwibank won't bring banking Revolut-ion

Forget Kiwibank. Revolut is the force big banks will have to reckon with, expert says.

FMA to oversee ‘regulatory sandbox’ for fintechs
Finance

FMA to oversee ‘regulatory sandbox’ for fintechs

The initiative aims to speed up financial services innovation and regulation in NZ.

Ben Moore 12 Dec 2024
Todd Corp: what went wrong?
Finance

Todd Corp: what went wrong?

A dividend freeze as the family empire rebuilds for the future.

Pattrick Smellie 12 Dec 2024